• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

2
results for

"Selective Serotonin Reuptake Inhibitors"

Filter

Article category

Keywords

Publication year

Authors

"Selective Serotonin Reuptake Inhibitors"

Review Article

Review of hormonal replacement therapy options for the treatments of menopausal symptoms
Melissa Edelweishia, Andreas Christoper, Evelyne Theresia, Veronica Angelia
Korean J Fam Med 2025;46(5):299-306.   Published online September 20, 2025
DOI: https://doi.org/10.4082/kjfm.25.0039
Menopause is a natural part of the aging process that every woman experiences at some point in life. Menopausal symptoms have a negative impact on the quality of life. Common menopausal symptoms include vasomotor symptoms, mood swings, concentration issues, vaginal dryness, atrophy of secondary sexual traits, libido loss, musculoskeletal discomfort, osteopenia, and osteoporosis. The most effective treatment for the relief of menopausal symptoms is estrogen, with or without. Hormone replacement therapy (HRT) is most beneficial before 60 years of age or within 10 years of menopause. Other menopause-related symptoms including mood swings, sleep disturbance, sexual dysfunction, and myalgia may improve with HRT. HRT is also effective in preventing bone loss associated with menopause and in reducing the incidence of all osteoporosis-related fractures, including those of the vertebrae and hip.
  • 778 View
  • 53 Download
Case Report
Escitalopram-Induced Amenorrhea and False Positive Urine Pregnancy Test
Vithyalakshmi Selvaraj, Siv Hour, Palanikumar Gunasekar, Caron Gray, James F. Smith
Korean J Fam Med 2017;38(1):40-42.   Published online January 18, 2017
DOI: https://doi.org/10.4082/kjfm.2017.38.1.40

Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.

Citations

Citations to this article as recorded by  
  • False-positive urine pregnancy screening tests are uncommon in the hospital setting among patients with bowel-containing urinary tract reconstruction
    Alyssia Venna, Marie-Therese Valovska, Carlos R. Estrada, Joseph G. Borer, Caleb P. Nelson
    Journal of Pediatric Urology.2023; 19(3): 312.e1.     CrossRef
  • Vortioxetine-Induced Amenorrhea: A Case Report
    Mesut Işik, Faruk Kurhan, Tuba Ülkevan, Pinar Güzel Özdemir
    Clinical Neuropharmacology.2022; 45(1): 7.     CrossRef
  • 7,629 View
  • 66 Download
  • 3 Web of Science
  • 2 Crossref
TOP